These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 32657585)

  • 21. Design, Synthesis, and Biological Evaluation of 1-Methyl-1,4-dihydroindeno[1,2-c]pyrazole Analogues as Potential Anticancer Agents Targeting Tubulin Colchicine Binding Site.
    Liu YN; Wang JJ; Ji YT; Zhao GD; Tang LQ; Zhang CM; Guo XL; Liu ZP
    J Med Chem; 2016 Jun; 59(11):5341-55. PubMed ID: 27172319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic interaction of N-3-Br-benzyl-noscapine and docetaxel abrogates oncogenic potential of breast cancer cells.
    Dash SG; Kantevari S; Pandey SK; Naik PK
    Chem Biol Drug Des; 2021 Sep; 98(3):466-479. PubMed ID: 34107169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural investigations into the binding mode of a novel noscapine analogue, 9-(4-vinylphenyl) noscapine, with tubulin by biochemical analyses and molecular dynamic simulations.
    Mahaddalkar T; Naik PK; Choudhary S; Manchukonda N; Kantevari S; Lopus M
    J Biomol Struct Dyn; 2017 Aug; 35(11):2475-2484. PubMed ID: 27576773
    [No Abstract]   [Full Text] [Related]  

  • 24. Novel third-generation water-soluble noscapine analogs as superior microtubule-interfering agents with enhanced antiproliferative activity.
    Henary M; Narayana L; Ahad S; Gundala SR; Mukkavilli R; Sharma V; Owens EA; Yadav Y; Nagaraju M; Hamelberg D; Tandon V; Panda D; Aneja R
    Biochem Pharmacol; 2014 Nov; 92(2):192-205. PubMed ID: 25124704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular modelling studies on Arylthioindoles as potent inhibitors of tubulin polymerization.
    Coluccia A; Sabbadin D; Brancale A
    Eur J Med Chem; 2011 Aug; 46(8):3519-25. PubMed ID: 21621885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 1,3-Benzodioxole-Modified Noscapine Analogues: Synthesis, Antiproliferative Activity, and Tubulin-Bound Structure.
    Yong C; Devine SM; Abel AC; Tomlins SD; Muthiah D; Gao X; Callaghan R; Steinmetz MO; Prota AE; Capuano B; Scammells PJ
    ChemMedChem; 2021 Sep; 16(18):2882-2894. PubMed ID: 34159741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-mitotic activity of colchicine and the structural basis for its interaction with tubulin.
    Bhattacharyya B; Panda D; Gupta S; Banerjee M
    Med Res Rev; 2008 Jan; 28(1):155-83. PubMed ID: 17464966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potent anti-inflammatory activity of novel microtubule-modulating brominated noscapine analogs.
    Zughaier S; Karna P; Stephens D; Aneja R
    PLoS One; 2010 Feb; 5(2):e9165. PubMed ID: 20161797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New ligands of the tubulin colchicine site based on X-ray structures.
    Álvarez R; Medarde M; Peláez R
    Curr Top Med Chem; 2014; 14(20):2231-52. PubMed ID: 25434358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New indole-based chalconoids as tubulin-targeting antiproliferative agents.
    Mirzaei H; Shokrzadeh M; Modanloo M; Ziar A; Riazi GH; Emami S
    Bioorg Chem; 2017 Dec; 75():86-98. PubMed ID: 28922629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and biological evaluation of noscapine analogues as microtubule-interfering agents.
    Dai HL; Zheng JB; Lin M; Zheng J; Zhou FS; Dong XC; Guo L; Liu JW; Wen R
    Yao Xue Xue Bao; 2012 Oct; 47(10):1347-57. PubMed ID: 23289148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemical characterization and molecular dynamic simulation of β-sitosterol as a tubulin-binding anticancer agent.
    Mahaddalkar T; Suri C; Naik PK; Lopus M
    Eur J Pharmacol; 2015 Aug; 760():154-62. PubMed ID: 25912799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel orally active microtubule destabilizing agent S-40 targets the colchicine-binding site and shows potent antitumor activity.
    Du T; Lin S; Ji M; Xue N; Liu Y; Zhang Z; Zhang K; Zhang J; Zhang Y; Wang Q; Sheng L; Li Y; Lu D; Chen X; Xu H
    Cancer Lett; 2020 Dec; 495():22-32. PubMed ID: 32931884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 4(1H)-quinolone derivatives overcome acquired resistance to anti-microtubule agents by targeting the colchicine site of β-tubulin.
    Lin MS; Hong TM; Chou TH; Yang SC; Chung WC; Weng CW; Tsai ML; Cheng TR; Chen JJW; Lee TC; Wong CH; Chein RJ; Yang PC
    Eur J Med Chem; 2019 Nov; 181():111584. PubMed ID: 31419740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis and biological evaluation of a novel tubulin inhibitor SKLB0565 targeting the colchicine binding site.
    Hu X; Li L; Zhang Q; Wang Q; Feng Z; Xu Y; Xia Y; Yu L
    Bioorg Chem; 2020 Apr; 97():103695. PubMed ID: 32120073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quinolin-6-Yloxyacetamides Are Microtubule Destabilizing Agents That Bind to the Colchicine Site of Tubulin.
    Sharma A; Sáez-Calvo G; Olieric N; de Asís Balaguer F; Barasoain I; Lamberth C; Díaz JF; Steinmetz MO
    Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28640209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 9-PAN promotes tubulin- and ROS-mediated cell death in human triple-negative breast cancer cells.
    Verma P; Nagireddy PKR; Prassanawar SS; Nirmala JG; Gupta A; Kantevari S; Lopus M
    J Pharm Pharmacol; 2020 Nov; 72(11):1585-1594. PubMed ID: 32959391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting Tubulin-colchicine Site for Cancer Therapy: Inhibitors, Antibody- Drug Conjugates and Degradation Agents.
    Duan Y; Liu W; Tian L; Mao Y; Song C
    Curr Top Med Chem; 2019; 19(15):1289-1304. PubMed ID: 31210108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of noscapine derivatives as potential β-tubulin inhibitors.
    Nemati F; Salehi P; Bararjanian M; Hadian N; Mohebbi M; Lauro G; Ruggiero D; Terracciano S; Bifulco G; Bruno I
    Bioorg Med Chem Lett; 2020 Oct; 30(20):127489. PubMed ID: 32784088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 9-Arylimino noscapinoids as potent tubulin binding anticancer agent: chemical synthesis and cellular evaluation against breast tumour cells.
    Patel AK; Meher RK; Nagireddy PK; Pragyandipta P; Pedapati RK; Kantevari S; Naik PK
    SAR QSAR Environ Res; 2021 Apr; 32(4):269-291. PubMed ID: 33687299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.